Trials / Completed
CompletedNCT00647920
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
Study of the Human Anti-TNF-Antibody Adalimumab
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-Blind, Placebo-Controlled, Study of the Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated with Methotrexate
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | adalimumab | 40 mg adalimumab sc, every other week |
| BIOLOGICAL | placebo | placebo sc, every other week |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2005-04-01
- First posted
- 2008-04-01
- Last updated
- 2008-04-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00647920. Inclusion in this directory is not an endorsement.